Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3105 results found
Expand All
Apply All
3105 results found

BIO’s Dr. Clint Nesbitt Named to APLU-AAVMC Task Force on Gene Editing in Animal Agriculture
Share
Press Release  •  June 11, 2020
Washington, D.C. (June 11, 2020) – Dr. Clint Nesbitt, Senior Director of Science and Regulatory Affairs for Food & Agriculture at the Biotechnology Innovation Organization (BIO), was named today to a Task Force on Gene Editing in Animal Agriculture. The Task Force is being led by the Association of Public and Land-grant Universities (APLU) and the Association of American Veterinary Medical Colleges (AAVMC). “We applaud the APLU and the AAVMC for launching this initiative that brings academic experts to the table,” said Dana O’Brien, BIO's Executive Vice President for Food & Agriculture. “We’re honored that Clint will be representing BIO among this impressive slate of individuals, some of the foremost animal science leaders in the world.” The 11-person panel is comprised of scientists and industry leaders who will develop recommendations for regulating the use of gene editing in animal agriculture with appropriate safeguards and procedures. “Animal biotechnology has enormous potential to address animal health and welfare, and numerous agricultural, environmental, humanitarian, and public health challenges, including helping to prevent and respond to zoonotic diseases such as COVID-19,” said Nesbitt. “New biotech methods like gene editing can make animals resistant to disease and enhance animal well-being. But an optimal regulatory system for animal biotechnology needs to address safety and oversight while paving the way for innovation to flourish,” Nesbitt added. In a letter sent last week to Congressional leaders, BIO joined with 27 members of the Council of State Bioscience Associations calling for legislative action to streamline the regulatory oversight of animal biotechnology. According to the APLU and the AAVMC, the task force was born out of a September 2019 symposium, “Gene Editing in Livestock: Looking to the Future,” which the two associations organized. During that event, 23 of the nation’s leading experts from academia, government,…
Read More

What the FDA Commissioner said about trials and collaboration
Share
Good Day BIO Newsletter  •  June 11, 2020
It’s the last day of the BIO Digital education sessions, but the fun continues all day long at www.bio.org. Right now, we’re recapping what FDA Commissioner Dr. Stephen M. Hahn said during yesterday’s fireside chat and unpacking the latest news on when you might fly a biofuel-powered plane, in around 740 words, or 3 minutes, 40 seconds. We’ve expanded our list this week to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through today. Like what you see? Opt in here to keep receiving this email after the event.
Read More

What the FDA Commissioner said about trials and collaboration
Share
Good Day BIO Newsletter  •  June 11, 2020
It’s the last day of the BIO Digital education sessions, but the fun continues all day long at www.bio.org. Right now, we’re recapping what FDA Commissioner Dr. Stephen M. Hahn said during yesterday’s fireside chat and unpacking the latest news on when you might fly a biofuel-powered plane, in around 740 words, or 3 minutes, 40 seconds. We’ve expanded our list this week to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through today. Like what you see? Opt in here to keep receiving this email after the event.
Read More

What the FDA Commissioner said about trials and collaboration
Share
Good Day BIO Newsletter  •  June 11, 2020
It’s the last day of the BIO Digital education sessions, but the fun continues all day long at www.bio.org. Right now, we’re recapping what FDA Commissioner Dr. Stephen M. Hahn said during yesterday’s fireside chat and unpacking the latest news on when you might fly a biofuel-powered plane, in around 740 words, or 3 minutes, 40 seconds. We’ve expanded our list this week to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through today. Like what you see? Opt in here to keep receiving this email after the event.
Read More

What the FDA Commissioner said about trials and collaboration
Share
Good Day BIO Newsletter  •  June 11, 2020
It’s the last day of the BIO Digital education sessions, but the fun continues all day long at www.bio.org. Right now, we’re recapping what FDA Commissioner Dr. Stephen M. Hahn said during yesterday’s fireside chat and unpacking the latest news on when you might fly a biofuel-powered plane, in around 740 words, or 3 minutes, 40 seconds. We’ve expanded our list this week to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through today. Like what you see? Opt in here to keep receiving this email after the event.
Read More

BIO Digital Day #4: Heal our social genome.
Share
Good Day BIO Newsletter  •  June 11, 2020
We’ve come (almost) to the end of our first-ever virtual convention, which welcomed more than 7,000 attendees from 64 countries, for 524 sessions and 27,000 partnering meetings across 28 time zones (there are 37, we Googled it for you). Whew!  Before we sign off, here’s a quick recap of BIO Digital Day 4.
Read More

“We’ve never seen anything like this before.”
Share
Good Day BIO Newsletter  •  June 10, 2020
It’s Day 3 of BIO Digital. In today's news, we’re digging into BIO’s new report on emerging therapeutic investment, and specifically what it means for COVID, as well as taking a closer look at what Dr. Fauci said about COVID-19's impact on African Americans and what we can do about it. Here are around 900 words, just under 5 minutes. P.S. Can’t get enough Dr. Fauci? Join the fan club.  We’ve expanded our list to include the BIO Digital and convention community, and we’ll be sending a morning and special evening edition each day through the week. Like what you see? Opt in here to keep receiving this email after the event.
Read More

BIO Digital Day #3: Say goodbye to business as usual.
Share
Good Day BIO Newsletter  •  June 10, 2020
COVID-19 is having a dramatic impact on everything—from how we interact with patients, to how we think about mental health, and even how we do our science. Here’s a quick recap of BIO Digital Day 3.Like what you see? Click here to opt in to continue receiving Good Day BIO after the event.
Read More

The bioeconomy will carry us through
Share
Good Day BIO Newsletter  •  June 9, 2020
BIO Digital continues today—and yes, it’s Dr. Fauci Day! He will join our all-star vaccines panel featuring Johnson & Johnson, Merck, Moderna, Novavax, and Sanofi. To get ready, listen to the latest episode of the I AM BIO Podcast, featuring CEPI CEO Dr. Richard Hatchett, who will also participate. (You can listen via Apple, Google, Spotify, or wherever you get your podcasts.) Today, we take a closer look at our new report on the biotech economy, as well as a study showing why it’s so hard to determine the precise origin of the coronavirus. As always, DC news at the end. Here are around 960 words, just under 5 minutes.
Read More

BIO Digital Day #2: Dr. Fauci!
Share
Good Day BIO Newsletter  •  June 9, 2020
What's Dr. Fauci's worst nightmare? When will we have a vaccine? What does he really think about Brad Pitt playing him on SNL? We got these answers and more today. Here’s a quick recap of BIO Digital Day 2. Like what you see? Click here to opt in to continue receiving Good Day BIO after the event.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 221
  • 222
  • 223
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO